01 1Centaur Pharmaceuticals
01 1CHLORDIAZEPOXIDE HCL USP
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2021-09-24
Pay. Date : 2021-08-25
DMF Number : 35794
Submission : 2021-03-25
Status : Active
Type : II
20
Centaur Pharmaceuticals Pvt Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is CHLORDIAZEPOXIDE HCL USP, with a corresponding US DMF Number 35794.
Remarkably, this DMF maintains an Active status since its submission on March 25, 2021, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of September 24, 2021, and payment made on August 25, 2021, indicating their dedication to facilitating drug approvals, Categorized as Type II
